N4 Pharma(GB:THAT)
GBX 0.580.00 (0.00%)
GB:THAT
N4 Pharma ownership
GBX 0.58
At close:0.00 (0.00%)
Want to see GB:THAT full AI Analyst Report?
N4 Pharma (THAT) Ownership - Who Owns N4 Pharma?
7 Followers
N4 Pharma (THAT) Ownership Overview
- 0.19% Insiders
- 99.81% Public Companies and Individual Investors
The ownership structure of N4 Pharma (GB:THAT) stock is a mix of institutional, retail, and individual investors. , 0.19% is owned by Insiders, and 99.81% is owned by Public Companies and Individual Investors.
The ownership structure of N4 Pharma (GB:THAT) stock is a mix of institutional, retail, and individual investors. , 0.19% is owned by Insiders, and 99.81% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Jun 23, 2026 | David Horn Solomon | £100,000 | |
| Jun 23, 2026 | Alastair Smith | £100,000 | |
| Jun 23, 2026 | Michael Gavin Palfreyman | £13,000 | |
| Jun 23, 2026 | Christopher Jonathan Britten | £10,000 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Luke Cairns | 3,392,858 | Insider | 0.19% | 23,750 |
FAQ
What percentage of N4 Pharma (GB:THAT) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.81% of N4 Pharma (GB:THAT) stock is held by public companies and individual investors.
Who owns the most shares of N4 Pharma (GB:THAT)?
Luke Cairns owns the most shares of N4 Pharma (GB:THAT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
